Arvinas, Inc. (ARVN)
11.89
+0.16
(+1.36%)
USD |
NASDAQ |
Dec 31, 13:18
Arvinas EPS Diluted (Quarterly): -0.4795 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Verastem, Inc. | -1.347 |
| Sarepta Therapeutics, Inc. | -1.795 |
| Genprex, Inc. | -4.996 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -35.10M |
| Revenue (Quarterly) | 41.90M |
| Total Expenses (Quarterly) | 77.00M |
| Enterprise Value | -24.75M |
| Gross Profit Margin (Quarterly) | 96.90% |
| Profit Margin (Quarterly) | -83.77% |
| Earnings Yield | -6.75% |
| Normalized Earnings Yield | -6.690 |